Show simple item record

Long-term survivors among patients with cancer of unknown primary

dc.contributor.authorPavlidis, Nicholasen
dc.contributor.authorPetrakis, Dimitriosen
dc.contributor.authorGolfinopoulos, Vassilisen
dc.contributor.authorPentheroudakis, Georgeen
dc.creatorPavlidis, Nicholasen
dc.creatorPetrakis, Dimitriosen
dc.creatorGolfinopoulos, Vassilisen
dc.creatorPentheroudakis, Georgeen
dc.date.accessioned2018-06-22T09:54:16Z
dc.date.available2018-06-22T09:54:16Z
dc.date.issued2012
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/42274
dc.description.abstractThere is a general conception among oncologists that CUP patients behave poorly to treatment and carry a dismal survival. In this paper we are trying to elucidate the different groups of CUP patients and to describe in details the diagnostic and therapeutic management of the prognostically favorable patients. Clinicians should be aware that the favorable CUP cases must be treated according to recent guidelines with either specific locoregional and/or systemic therapy and that they commonly enjoy a long survival. Survival data of 219 CUP patients treated at Ioannina University Hospital from 1995 until 2011 are also presented. © 2012 Elsevier Ireland Ltd.en
dc.language.isoengen
dc.sourceCritical reviews in oncology/hematologyen
dc.subjectFemaleen
dc.subjectMaleen
dc.subjectAntineoplastic agenten
dc.subjectEtoposideen
dc.subjectHumanen
dc.subjectNeoplasmsen
dc.subjectHumansen
dc.subjectCancer survivalen
dc.subjectTaxane derivativeen
dc.subjectCytoreductive surgeryen
dc.subjectReviewen
dc.subjectCancer prognosisen
dc.subjectSurvivalen
dc.subjectBone metastasisen
dc.subjectMelanomaen
dc.subjectPlatinum complexen
dc.subjectTrastuzumaben
dc.subjectClinical featureen
dc.subjectHistopathologyen
dc.subjectLymph node dissectionen
dc.subjectLymph node metastasisen
dc.subjectCancer incidenceen
dc.subjectColon canceren
dc.subjectAdenocarcinomaen
dc.subjectCancer of unknown primary siteen
dc.subjectUnknown primaryen
dc.subjectProstate specific antigenen
dc.subjectNeuroendocrine tumoren
dc.subjectCancer of unknown primaryen
dc.subjectSomatostatin derivativeen
dc.subjectHead and neck squamous cell carcinomaen
dc.subjectAndrogen deprivation therapyen
dc.subjectAxillary nodal metastasisen
dc.subjectFavorable subsetsen
dc.subjectImmunochemistryen
dc.subjectMelanoma of unknown primaryen
dc.subjectNeuroendocrine carcinoma of unknown primaryen
dc.subjectPeritoneum tumoren
dc.subjectPoorly differentiated carcinoma with midline distributionen
dc.subjectPrimary peritoneal adenocarcinomaen
dc.subjectSquamous cell carcinoma involving cervical lymph nodeen
dc.subjectSurvivorsen
dc.titleLong-term survivors among patients with cancer of unknown primaryen
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.critrevonc.2012.02.002
dc.description.volume84
dc.description.issue1
dc.description.startingpage85
dc.description.endingpage92
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidPavlidis, Nicholas [0000-0002-2195-9961]
dc.contributor.orcidPentheroudakis, George [0000-0002-6632-2462]
dc.gnosis.orcid0000-0002-2195-9961
dc.gnosis.orcid0000-0002-6632-2462


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record